BC Extra | Jun 8, 2017
Clinical News

Cyclin D3-CDK6 levels predict tumor response to CDK4/6 inhibitors

In an article published online in Nature on Wednesday, scientists reported that high levels of tumor cyclin D3-cyclin-dependent kinase 6 ( CDK6 ) correlated with long-term tumor regression after blockade of CDK4 and CDK6. Inhibitors of CDK4...
BC Innovations | Feb 26, 2009
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer Cyclin-dependent kinase 4 (CDK4); cyclin D3 (CCND3) Structural determination of the CDK4-CCND3 complex could be useful for identifying...
BC Innovations | Jun 19, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML); leukemia; multiple myeloma (MM) Cyclin D1 (CCND1; BCL1); cyclin D2 (CCND2); cyclin D3 (CCND3) Studies in...
BC Innovations | May 8, 2008
Targets & Mechanisms

D-coupling Multiple Myeloma's Codependents

Three years ago researchers at the Mayo Clinic Arizona reported that most types of multiple myeloma overexpress cyclin D1 and/or cyclin D2. 1 Following on that earlier work, a new research team at the clinic...
BC Week In Review | Aug 17, 1998
Company News

Alfacell other research news

ACEL described in Leukemia a mechanism by which Onconase may regulate cancer cell growth. Human lymphoma cells treated with Onconase arrested in the G1 phase of the cell cycle, resulting in reduced proliferation and apoptosis...
Items per page:
1 - 5 of 5